Avalo Therapeutics, Inc. (AVTX) vs Olema Pharmaceuticals, Inc. (OLMA)
A side-by-side comparison of Avalo Therapeutics, Inc. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVTX
Avalo Therapeutics, Inc.
$13.37HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
OLMA
Olema Pharmaceuticals, Inc.
$8.10HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — AVTX vs OLMA
growth of $100 · dividends reinvested · last 6yAVTX -99.8% (-64.0%/yr)OLMA -83.2% (-25.7%/yr)OLMA compounded faster over this window
Log scale — wide-divergence pair
AVTX OLMA
AVTX vs OLMA: by the numbers
- •OLMA is the larger company ($707M vs $703M market cap).
- •Both run net losses; OLMA's is the smaller (0.00% vs -170055.93% net margin).
Metrics side by side
Valuation
| Metric | AVTX | OLMA |
|---|---|---|
| P/S ratio | 11910.30 | N/A |
| P/B ratio | 1.57 | 1.64 |
Profitability
| Metric | AVTX | OLMA |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -123601.69% | 0.00% |
| Net margin | -170055.93% | 0.00% |
| ROE | -22.36% | -47.51% |
| ROIC | -19.45% | -50.92% |
Growth (annualized)
| Metric | AVTX | OLMA |
|---|---|---|
| Revenue CAGR (5Y) | -60.88% | N/A |
| Total return CAGR (5Y) | -70.04% | -21.50% |
Frequently asked
- How have AVTX and OLMA total returns compared?
- Over the past 5 years, AVTX delivered -70.04% and OLMA delivered -21.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.